GlassScriptPhysician profile
James Matthew Tracey
NPI 1598102527
$2,925.59
in general payments reported to CMS, 2019-2025
21 companies · $1,516 in 2025
The $1,516 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $28.92 · 2021: $298 · 2022: $221 · 2023: $194 · 2024: $668 · 2025: $1,516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,368 · Travel and Lodging: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,368.44 |
| Travel and Lodging | $1,009.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,330.08 | 2025 | |
| Teleflex LLC | $406.72 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $129.48 | 2021-2025 | Spaceoar Vue System - 10ml |
| Pacira Pharmaceuticals Incorporated | $128.48 | 2024-2025 | Exparel |
| Progenics Pharmaceuticals, INC. | $124.26 | 2024 | |
| Cook Medical LLC | $99.47 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $96.57 | 2023-2024 | Gemtesa, Orgovyx |
| Coloplast Corp | $96.51 | 2023-2024 | Speedicath |
| Photocure INC | $79.65 | 2021 | |
| Ferring Pharmaceuticals INC. | $78.39 | 2024-2025 | Adstiladrin |
| Myovant Sciences INC. | $62.79 | 2021 | |
| 180 Medical, INC. | $50.03 | 2023-2024 | |
| Medtronic, INC. | $45.98 | 2022-2024 | Interstim |
| Abbvie INC. | $41.67 | 2024-2025 | |
| Urogen Pharma, INC. | $35.17 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $29.03 | 2023 | Uretero-Reno Fiberscope |
| Ethicon US, LLC | $27.75 | 2024 | Ethicon, Vistaseal, Stratafix |
| Tempus Ai, INC | $19.94 | 2025 | Xt Cdx |
| Axonics, INC. | $16.41 | 2022 | |
| Amgen INC. | $14.00 | 2022 | |
| Merck Sharp & Dohme LLC | $13.21 | 2023 | Lynparza, Welireg, Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tracey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.